These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22343838)

  • 1. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.
    Shafique K; Proctor MJ; McMillan DC; Qureshi K; Leung H; Morrison DS
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):195-201. PubMed ID: 22343838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of the role of inflammation in renal cancer.
    Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
    Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
    Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
    Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up.
    McArdle PA; Qayyum T; McMillan DC
    Urol Int; 2010; 84(4):430-5. PubMed ID: 20395655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostication in advanced cancer: a study examining an inflammation-based score.
    Partridge M; Fallon M; Bray C; McMillan D; Brown D; Laird B
    J Pain Symptom Manage; 2012 Aug; 44(2):161-7. PubMed ID: 22732417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
    Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
    Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
    Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
    Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients.
    Shafique K; Proctor MJ; McMillan DC; Leung H; Smith K; Sloan B; Morrison DS
    BMC Cancer; 2013 Jun; 13():292. PubMed ID: 23768149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
    Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
    BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
    Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
    J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
    Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
    J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases.
    Neal CP; Mann CD; Sutton CD; Garcea G; Ong SL; Steward WP; Dennison AR; Berry DP
    Eur J Cancer; 2009 Jan; 45(1):56-64. PubMed ID: 18848775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.
    Proctor MJ; McMillan DC; Horgan PG; Fletcher CD; Talwar D; Morrison DS
    PLoS One; 2015; 10(3):e0116206. PubMed ID: 25730322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.